Company Filing History:
Years Active: 2002-2007
Title: Innovations of Zhongming Ge
Introduction
Zhongming Ge is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of glycosyltransferases. With a total of 5 patents, his work has implications for both research and diagnostic applications in medicine.
Latest Patents
One of Zhongming Ge's latest patents involves a bacterial α1,3-fucosyltransferase gene and its deduced amino acid sequence. This gene is instrumental in preparing α1,3-fucosyltransferase polypeptides and their active fragments. These polypeptides can be utilized in the production of oligosaccharides such as Lewis X, Lewis Y, and sialyl Lewis X. These oligosaccharides are structurally similar to certain tumor-associated carbohydrate antigens found in mammals. The glycoconjugates produced from this invention have significant research and diagnostic utility, particularly in developing assays to detect mammalian tumors. Furthermore, the polypeptide can be employed to create diagnostic and research assays to determine the presence of specific human specimens.
Career Highlights
Zhongming Ge is affiliated with the University of Alberta, where he continues to advance his research and innovation in the field of biotechnology. His work has garnered attention for its potential applications in medical diagnostics and therapeutic development.
Collaborations
Zhongming Ge collaborates with Diane E Taylor, contributing to the advancement of their shared research interests.
Conclusion
Zhongming Ge's innovative work in biotechnology, particularly through his patents, showcases his commitment to advancing medical research and diagnostics. His contributions are paving the way for future developments in the field.